Evidence map›Paper›PMID 29113408›Full record

ArticleOncotarget2017

Liver resection

Chuan Li, Jia-Ye Liu, Wei Peng, Tian-Fu Wen, Lu-Nan Yan, Jia-Yin Yang, Bo Li, Wen-Tao Wang, Ming-Qing Xu

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Improving surgical treatments for hepatocellular carcinoma.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chuan LiDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Jia-Ye LiuDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Wei PengDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Tian-Fu WenDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Lu-Nan YanDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Jia-Yin YangDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Bo LiDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Wen-Tao WangDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Ming-Qing XuDepartment of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to compare the outcomes of patients with multiple hepatocellular carcinoma (HCCs) after liver resection (LR) versus liver transplantation (LT). Patients who had multiple HCCs without macrovascular invasion and who underwent LT or LR between 2007 and 2013 were reviewed. A propensity score matching model was used to adjust baseline differences between the two groups. A total of 204 patients were selected for the current study, including 137 LR patients and 67 LT patients. During follow-up, 100 patients experienced recurrence, and 78 patients died. The 5-year recurrence-free survival rate was 71.1% for the LT group and 31.1% for the LR group (P<0.001). The 5-year overall survival rate was 73.4% for the LT group and 39.8% for the LR group (P<0.001). Moreover, the LT group had better recurrence-free survival and overall survival rates than the LR group regardless of whether the patients met or exceeded the Milan criteria. The multivariate analysis showed that microvascular invasion and LR were independent risk factors for postoperative recurrence, whereas only LR was associated with an increased incidence of mortality. After applying one-to-one propensity score matching, similar results were observed in the propensity score matching model. Our study suggested that LT provided a better prognosis for patients with multiple HCCs than LR regardless of whether the patients met the Milan criteria.

Indexed as

hepatocellular carcinomaliver resectionliver transplantationoutcomesrecurrence

Identifiers

PMID29113408
PMCPMC5655303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.